Login / Signup
Tocilizumab and other targeted therapies for severe cutaneous immune-related adverse events.
L L Thompson
Steven T Chen
Published in:
The British journal of dermatology (2020)
Keyphrases
</>
rheumatoid arthritis
juvenile idiopathic arthritis
early onset
drug induced